Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

252.95
Delayed Data
As of Jul 29
 -2.61 / -1.02%
Today’s Change
195.50
Today|||52-Week Range
340.34
-19.06%
Year-to-Date
Allergan (AGN) Stock Is Thursday's 'Chart of the Day'
Jul 28 / TheStreet.com - Paid Partner Content
Jerome Dodson Comments on Allergan
Jul 26 / GuruFocus News - Paid Partner Content
Allergan Cures Its Ailing Chart
Jul 28 / TheStreet.com - Paid Partner Content
Jerome Dodson's Parnassus Fund 2nd Quarter Commentary
Jul 26 / GuruFocus News - Paid Partner Content
Jerome Dodson's Best Investments
Jul 27 / GuruFocus News - Paid Partner Content
Jim Cramer -- I Agree With the Analysts on Gap, Allergan
Jul 25 / TheStreet.com - Paid Partner Content
Daniel Loeb's Third Point 2nd-Quarter 2016 Investor Letter
Jul 27 / GuruFocus News - Paid Partner Content
5 Incredibly Cheap Big Pharma Stocks
Jul 25 / MotleyFool.com - Paid Partner Content
3 Stocks Improving Performance Of The Health Care Sector
Jul 26 / TheStreet.com - Paid Partner Content
Analysts' Actions -- Allergan, Alaska Air, Tableau, PulteGroup and More
Jul 25 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close255.56
Today’s open255.67
Day’s range251.94 - 255.70
Volume2,287,586
Average volume (3 months)4,578,382
Market cap$100.1B
Dividend yield--
Data as of 4:00pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+5.59%
Earnings growth (next 5 years)+11.20%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+1.51+2.33%
LLYEli Lilly and Co-0.04-0.05%
GSKGlaxoSmithKline-0.11-0.24%
SNYSanofi+0.03+0.07%
Data as of 4:02pm ET, 07/29/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)$3.32
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs